Status:

UNKNOWN

Effects of a Multispecies Probiotic on Migraine

Lead Sponsor:

Scripps Health

Collaborating Sponsors:

Kaneka Corporation

Conditions:

Migraine

Irritable Bowel Syndrome

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The prevalence of migraine is higher in female patients with various intestinal diseases. An explanation could be that migraine is caused by a leaky gut, defined by increased intestinal permeability t...

Detailed Description

Given the significant unmet need for improved therapies that address migraine disorders and concurrent irritable bowel syndrome (IBS), this study seeks to investigate the impact of probiotics on the s...

Eligibility Criteria

Inclusion

  • Episodic migraine diagnosis for a minimum of 1 year (12-months)
  • Between 3-12 migraine episodes /month
  • Comorbid, symptomatic, irritable bowel syndrome during the screening period
  • On a steady treatment regimen: preventative and acute migraine medications and therapies unchanged over the last 6 months
  • Access to Scripps Center for Integrative Medicine
  • Access to smartphone or computer to complete electronic surveys

Exclusion

  • Other GI or hepatic diagnoses (Inflammatory Bowel Disease (IBD), Small Intestinal Bacterial Overgrowth (SIBO), Non-Alcoholic Fatty Liver Disease (NAFLD), elevated Liver Function Tests (LFTs) within the last 6 months)
  • Prior GI surgery
  • Prior GI infection in the previous 3-months
  • Antibiotic treatment in previous last 3 months
  • Diagnosed Autoimmune disease
  • Current corticosteroids use
  • Morbid obesity (BMI \>40)
  • Took Probiotics or Probiotic-containing supplements or therapy in the previous 3-months
  • Diagnosis of post-traumatic headache or cervicogenic headache
  • Pregnancy or plans to become pregnant during study participation

Key Trial Info

Start Date :

April 15 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04696458

Start Date

April 15 2021

End Date

April 1 2024

Last Update

November 23 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Scripps Center for Integrative Medicine

La Jolla, California, United States, 92307